Advanced Parkinson's disease: clinical characteristics and treatment. Part II.
Explore this paper's citation graph
Summary
The literature concerning the indications and results of deep brain stimulation, subcutaneous apomorphine infusion and duodenal infusion of levodopa/carbidopa gel to treat patients with advanced Parkinson disease are reviewed.
- Type
- review
- Published
- 2013-11-01
- Cited by
- 49
- References
- 421
- Access
- Open access
- OpenAlex
- https://openalex.org/W2039780134
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:6858423
Keywords
Medicine, Deep brain stimulation, Subthalamic nucleus, Levodopa, Carbidopa
References
- Letter: Motor-neurone disease in Israel.
- Sleep disorders and sleep effect in Parkinson's disease
- Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation
- Health related quality of life in Parkinson's disease: a systematic review of disease specific instruments
- Treatment of Psychosis in Parkinson’s Disease
- Unilateral pallidotomy versus bilateral subthalamic nucleus stimulation in Parkinson’s disease: one year follow-up of a randomised observer-blind multi centre trial
- Two questionnaires for Parkinson’s disease: are the PDQ-39 and PDQL equivalent?
- Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; Study using nonmotor symptoms questionnaire in 545 patients
- When does Parkinson's disease begin?
- Progression and prognostic factors of motor impairment, disability and quality of life in newly diagnosed Parkinson's disease
- The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the Non-Motor Symptoms of Parkinson's Disease
- Assessment of sleep and sleepiness in Parkinson disease.
- [Efficacy and safety of galantamine (reminyl) in the treatment of dementia in patients with Parkinson's disease (open-label controlled trial)].
- A randomised controlled cross-over trial of aerobic training versus Qigong in advanced Parkinson's disease.
- A comparison of speech and language therapy techniques for dysarthria in Parkinson's disease.
- A new method for measuring daytime sleepiness: the Epworth sleepiness scale.
- Meta‐analysis: antibiotic prophylaxis to prevent peristomal infection following percutaneous endoscopic gastrostomy
- Randomized trial of tolcapone versus pergolide as add‐on to levodopa therapy in Parkinson's disease patients with motor fluctuations
- Depression and Parkinson's disease: a review.
- Dysautonomia Rating Scales in Parkinson’s Disease: Sialorrhea, Dysphagia, and Constipation—Critique and Recommendations by Movement Disorders Task Force on Rating Scales for Parkinson’s Disease
Cited by
- Nanoparticle technology for treatment of Parkinson's disease: the role of surface phenomena in reaching the brain.
- Enfermedades neurológicas y psiquiátricas en el anciano
- Solid Microneedles for Transdermal Delivery of Amantadine Hydrochloride and Pramipexole Dihydrochloride
- Advanced Parkinson's disease: Clinical characteristics and treatment. Part II
- Stem Cell Therapy in the Treatment of Neurological Diseases
- Clinical profile of Parkinson's disease in the Gumei community of Minhang district, Shanghai
- Prevalence and factors associated with polyneuropathy in Parkinson’s disease
- Infusion treatments and deep brain stimulation in Parkinson's Disease: The role of nursing.
- Estrategias psicosociales para fortalecer el afrontamiento de la enfermedad de Parkinson: perspectiva de pacientes, familiares y profesionales sociosanitarios
- 24/7 Live Stream Telemedicine Home Treatment Service for Parkinson's Disease Patients
- A meta-analysis of the pedunculopontine nucleus deep-brain stimulation effects on Parkinson’s disease
- Experience with the use of rivastigmine in patients with Parkinson’s disease and cognitive disorders
- Duodenal Levodopa Infusion for Long-Term Deep Brain Stimulation–Refractory Symptoms in Advanced Parkinson Disease
- Can suitable candidates for levodopa/carbidopa intestinal gel therapy be identified using current evidence?
- l‐Dopa/carbidopa intestinal gel and subthalamic nucleus stimulation: Effects on cognition and behavior
- Eficacia de los videojuegos comerciales en el tratamiento del equilibrio y la marcha en la enfermedad de Parkinson
- Continuous intestinal infusion of levodopa-carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous community.
- Effectiveness of Serious Games for Leap Motion on the Functionality of the Upper Limb in Parkinson's Disease: A Feasibility Study
- Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach
- Estudio de calidad de vida con la PDQ39 en pacientes con enfermedad de Parkinson tratados con terapias avanzadas
Related papers
- The effect of an increased ratio of carbidopa to levodopa on the pharmacokinetics of levodopa
- Increased dosage of carbidopa in parkinsonian patients on low carbidopa-levodopa regimen. Effect on levodopa bioavailability.
- Controlled release levodopa/carbidopa 25/100 (Sinemet CR 25/100): pharmacokinetics and clinical efficacy in untreated parkinsonian patients.
- Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease
- Two cases of unexpected long-term improvement of Parkinson's disease after subthalamic nucleus deep brain stimulation removal
- Effect of a slow release preparation of levodopa on Parkinson's disease in combination with a peripheral decarboxylase inhibitor
- Controlled-release carbidopa/levodopa (CR) in parkinsonian patients with response fluctuations on standard levodopa treatment: clinical and pharmacokinetic observations.
- Beginning-of-dose motor deterioration following the acute administration of levodopa and apomorphine in Parkinson's disease.
- Fluctuations in plasma levodopa and motor responses with liquid and tablet levodopa/carbidopa